Catalog
Bookmarks
0
Course Reserves
My Account
Advanced search
Search in
Keyword
Title
Author/Creator
Subject
Browse by LC Call Number
Browse by Author
Browse by Subject
search for
Search
Search
Advanced search
Start Over
Share
Email
RIS file
Bookmark
Report an Issue
Guidance for industry : ANDAs, impurities in drug substances
Additional Titles
ANDAs, impurities in drug substances
Published
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2009]
Physical Description
1 online resource (8 pages) : chart
Additional Creators
Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs
Access Online
purl.fdlp.gov
Full Text available online
Availability
I Want It
I Want It
Finding items...
Restrictions on Access
Free-to-read Unrestricted online access
Report Numbers
HE 20.4702:IM 7/5
Subject(s)
Drug adulteration
—
Government policy
—
United States
Drug approval
—
United States
Note
"Office of Generic Drugs."
"Revision 1."
"June 2009."
Action Note
committed to retain. Federal Depository Library Program (FDLP). For information on our retention commitment, please contact Microforms and Government Information.
View MARC record
| catkey: 5892854